Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Kazia Therapeutics Ltd (NASDAQ:KZIA)

2.70
Delayed Data
As of 9:37am ET
 +0.1323 / +5.15%
Today’s Change
1.63
Today|||52-Week Range
7.60
-53.92%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$12.4M

Company Description

Kazia Therapeutics Ltd. engages in the pharmaceutical drug development. It involves in preclinical research confirms efficacy of cantrixil which induces cell death in chemoresistant ovarian cancer stem cells. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Hornsby, Australia.

Contact Information

Kazia Therapeutics Ltd.
20 George Street
Hornsby New South Wales (nsw) 2077
P:(129) 472-4101
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

James GarnerChief Executive Officer & Executive Director
Gabrielle HeatonDirector-Finance & Administration
Gordon HirschChief Medical Officer
Peng LeongChief Business Officer
Kate HillSecretary